肠复康方治疗宫颈癌放疗后湿热蕴结下焦型放射性肠炎32例临床观察  

The Clinical Efficacy of Changfukang Formula in Dampness-Heat on Lower Energizer Type of Cervical Cancer: A Clinical Observation of 32 Cases

作　　者：王云启[1] 王希[2] 李玉明[1] 

机构地区：[1]湖南省肿瘤医院,湖南长沙410013 [2]湖南中医药大学

出　　处：《中医药导报》2014年第9期29-32,共4页Guiding Journal of Traditional Chinese Medicine and Pharmacy

基　　金：湖南省科技厅科研课题(2011SK3174)

摘　　要：目的:观察肠复康方治疗宫颈癌放疗后湿热蕴结下焦型放射性肠炎的临床疗效。方法:将64例宫颈癌放疗后湿热蕴结下焦型放射性肠炎患者随机分为治疗组和对照组,每组32例。治疗组予肠复康方口服;对照组服用思密达(蒙脱石散)口服。两组疗程均为2周,观察比较两组临床疗效。结果:治疗组在改善患者临床症状、大便常规+潜血、肠黏膜状况及生活质量等方面疗效均优于对照组,差异有统计学的意义(P<0.05)。结论:肠复康方治疗宫颈癌放疗后湿热蕴结下焦型放射性肠炎有较好疗效。Objective： To observe the clinical efficacy of Changfukang formula on dampness-heat in the lower energizer type of cervical cancer. Methods： The 64 patients were randomly divided into treatment and control groups, 32 cases in each. Patients were treated by Changfukang formula in treatment group and Smecta （montmorilionite powder） in control group. The treatment in both two groups lasted two weeks, and the clinical effect was compared. Resuhs： The treatment group showed better efficacy than the control group on improving clinical symptoms, stool ＋ occult blood, intestinal condition and quality of life and other aspects, and the differences was statistically significant （P〈0.05）.Conclusion： Changfukang formula take orally can provide good curative effect in dampness-heat in the lower energizer type of cervical cancer.

关 键 词：肠复康方 放射性肠炎 宫颈癌 湿热蕴结下焦 

分 类 号：R273[医药卫生—中西医结合]